Physician profile
Thomas Lafferty
NPI 1932191541
$1,639.87
in general payments reported to CMS, 2019-2025
8 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2022: $247 · 2023: $259 · 2024: $412 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,044 · Education: $19.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.80 |
| Education | $19.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $389.22 | 2022-2024 | |
| Ucb, INC. | $384.73 | 2019-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $244.30 | 2019-2025 | |
| Amgen INC. | $233.40 | 2019-2024 | Otezla |
| Aurinia Pharma U.S., INC. | $125.05 | 2022 | |
| Glaxosmithkline, LLC. | $122.75 | 2024 | Benlysta |
| Pfizer INC. | $121.17 | 2025 | |
| Sobi, INC | $19.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lafferty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.